Chinese Hepatitis B Therapeutic Vaccines Start Clinical Trials

liver411

Hello hep b:
>
>   I thought you might be interested in this China.org.cn story.
>Hepatitis B Therapeutic Vaccines Start Clinical Trials
>To learn more, visit http://www.china.org.cn/english/health/185706.htm
>Comments or concerns, Please e-mail us at [email protected]
>For more news and information, visit http://www.china.org.cn
>
>                                         Your friend   Jim

liver411

This is an example of what is possible out of China.

"Take the case of Wei Yuquan. Mr. Wei is vice president of Sichuan
University as well as an immunologist and a member of the Chinese Academy of
Sciences. A recent article by Mr. Wei describing an experiment to treat
cancer cells was billed as groundbreaking. Yet when Si Lu Sheng, a
relatively obscure older pathologist from central China, reviewed the
article, something stuck in his craw. Mr. Si asked Mr. Wei for simple
verification. But Wei refused to present basic evidence, discuss methods, or
even present receipts for lab purchases of special white mice. Yet on the
basis of the article, Wei received a $60,000 grant from China's National
Life Science and Nature fund - big money for professors here, some of whom
make only $350 a month.

Si was flabbergasted. Nearing retirement, and with little to lose, he
started a small campaign to expose what he felt was cheating, he told the
Monitor."


http://www.csmonitor.com/2006/0516/p01s03-woap.html



http://www.scidev.net/News/index.cfm?fuseaction=readNews&itemid=2793&language=1

"Wei is the latest addition to a growing list of Chinese researchers whose
work has been brought into question by the country's 'science police' — the
unofficial watchdogs such as Fang Zhouzi, the former biochemist who runs New
Threads (see Out to debunk China's 'science police').

Fang told SciDev.Net that, by exposing academic misconduct, he hopes to
encourage the creation of a formal system for ensuring academic ethics in
China."


http://www.csmonitor.com/2006/0516/p01s03-woap.html

"Research fraud rampant in China
A Chinese study found that 60 percent of PhD candidates admitted to
plagiarism, bribery."

IC

"不久前（对不起，我不记得具体时间了，大概至少是在1个多月以前），我参加了闻玉梅院士治疗性疫苗2期临床的“中期评估”，不知为何一个多月之后就“最后一例”了，因为，当时的评估结果并不十分乐观，有两点得到我们的关注：第一，疗效并没有超过现有的抗病毒药物；第二，副作用。大家都知道免疫复合物沉积于肾小球基底膜的后果，而且2期临床的确观察到了有尿液的异常改变。还给我留下深刻印象的是：开发公司很急。

第三军医大学是不是急躁了我不敢说，但是我清晰地记得当年国家同意给闻院士数百万元研制治疗性疫苗时的一件事，当时复旦大学想藉此大做文章，并邀请闻院士对记者说话，闻院士一口拒绝，理由很简单：这是科学研究，不能把探索中的问题报道出来。可是始料未及的是，在后来的一段时间里，闻老师的来信不断：都是病人“求医”的（闻院士不是医生），搞得闻老师哭笑不得。"

http://www.infectcma.org.cn/bbs/dispbbs.asp?boardID=40&RootID=5827&ID=5827

六个疫苗，没有一个“汉芯”，“龙芯”时代来了，虽然目前只能跑Linux，不过我相信星星之火，可以燎原。

[此贴子已经被作者于2006-12-1 5:43:32编辑过]

2002落叶

魏院士的论文叙述的确有不严谨的地方,其他也有一些毛病,但对他研究成果我是有信心的